Sign in

CIK 0001279704

  • Non-accelerated filer
  • Smaller reporting company

Cellectar Biosciences, Inc.

Sign in to watch
Ticker
CLRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043321804
Phone
+1 608-441-8120
Business address
100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
Former names
NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-07 Kolean Chad J CFO Grant or award · Stock option (right to buy) +92,000 92,000
2025-07-02 Kolean Chad J Chief Financial Officer Purchase +5,000 $4.99 $25K 6,418
2025-07-02 Kolean Chad J Chief Financial Officer Purchase · Warrants +5,000 $0.01 $50 5,000
2025-02-14 Kolean Chad J Chief Financial Officer Grant or award · Stock option (right to buy) +290,000 290,000
2024-06-14 Kolean Chad J Chief Financial Officer Grant or award · Stock option (right to buy) +290,000 290,000
2023-12-08 Kolean Chad J Chief Financial Officer Grant or award +42,554 42,578
2023-06-23 Kolean Chad J Chief Financial Officer Grant or award · Stock option (right to buy) +104,000 104,000
2023-01-17 Kolean Chad J Chief Financial Officer Grant or award · Stock option (right to buy) +104,000 104,000
2022-02-22 Kolean Chad J Chief Financial Officer Grant or award · Stock option (right to buy) +150,000 150,000
2017-04-18 Kolean Chad J VP, Chief Financial Officer Grant or award +80,000 80,000
2016-05-12 Kolean Chad J VP, CFO and Treasurer Grant or award · Stock option (right to buy) +50,000 $0.01 $500 52,000

Page 1 of 1 · 11 trades